Mednet Logo
HomeGynecologic OncologyQuestion

How should you manage a COVID-19 infected/suspected patient who is receiving chemotherapy and cannot interrupt or delay their cancer treatment?

8
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Fred Hutchinson Cancer Research Center

This is difficult to answer specifically without further details. There certainly is accumulating evidence that patients with cancer, especially those receiving immunosuppressive chemotherapy, are at greater risk of COVID-19 infection if exposed, and a greater risk of serious and life-threatening co...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · University of Iowa Holden Comprehensive Cancer Center

There are at least two published analyses showing increased severity and worse outcome from COVID-19 in cancer patients and recent anti-tumor therapy, like chemotherapy, strongly increases risk of severe events.

1) Liang et al published outcomes of 18 patients with cancer and lab-confirmed COVID-19, ...

Register or Sign In to see full answer